51
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Global Role and Burden of Influenza in Pediatric Respiratory Hospitalizations, 1982–2012: A Systematic Analysis

      research-article
      1 , 2 , * , 3 , 4 , 5 , 6 , 7 , 8 , 1 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 1 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 1 , 1 , 1 , 3 , 1 , * , Global Respiratory Hospitalizations—Influenza Proportion Positive (GRIPP) Working Group
      PLoS Medicine
      Public Library of Science
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          The global burden of pediatric severe respiratory illness is substantial, and influenza viruses contribute to this burden. Systematic surveillance and testing for influenza among hospitalized children has expanded globally over the past decade. However, only a fraction of the data has been used to estimate influenza burden. In this analysis, we use surveillance data to provide an estimate of influenza-associated hospitalizations among children worldwide.

          Methods and Findings

          We aggregated data from a systematic review ( n = 108) and surveillance platforms ( n = 37) to calculate a pooled estimate of the proportion of samples collected from children hospitalized with respiratory illnesses and positive for influenza by age group (<6 mo, <1 y, <2 y, <5 y, 5–17 y, and <18 y). We applied this proportion to global estimates of acute lower respiratory infection hospitalizations among children aged <1 y and <5 y, to obtain the number and per capita rate of influenza-associated hospitalizations by geographic region and socio-economic status.

          Influenza was associated with 10% (95% CI 8%–11%) of respiratory hospitalizations in children <18 y worldwide, ranging from 5% (95% CI 3%–7%) among children <6 mo to 16% (95% CI 14%–20%) among children 5–17 y. On average, we estimated that influenza results in approximately 374,000 (95% CI 264,000 to 539,000) hospitalizations in children <1 y—of which 228,000 (95% CI 150,000 to 344,000) occur in children <6 mo—and 870,000 (95% CI 610,000 to 1,237,000) hospitalizations in children <5 y annually. Influenza-associated hospitalization rates were more than three times higher in developing countries than in industrialized countries (150/100,000 children/year versus 48/100,000). However, differences in hospitalization practices between settings are an important limitation in interpreting these findings.

          Conclusions

          Influenza is an important contributor to respiratory hospitalizations among young children worldwide. Increasing influenza vaccination coverage among young children and pregnant women could reduce this burden and protect infants <6 mo.

          Abstract

          The substantial global burden of influenza infections in children is revealed by Lafond and colleagues. Children in developing countries are 3 times more likely to be hospitalised and treatments vary. This study highlights the need for vaccination programs in the young.

          Editors' Summary

          Background

          Acute lower respiratory infections—bacterial and viral infections of the lungs and airways (the tubes that take oxygen-rich air to the lungs)—are major causes of illness and death in children worldwide. Pneumonia (infection of the lungs) alone is responsible for 15% of deaths among children under five years old and kills nearly one million young children every year. Globally, infections with respiratory syncytial virus and with Streptococcus pneumoniae are associated with about 25% and 18.3%, respectively, of all episodes of severe respiratory infection in young children. Another infectious organism that contributes to the global burden of respiratory disease among children is the influenza virus. Every year, millions of people become infected with this virus, which infects the airways and causes symptoms that include a high temperature, tiredness and weakness, general aches and pains, and a dry chesty cough. Most infected individuals recover quickly, but seasonal influenza outbreaks (epidemics) nevertheless kill about half a million people annually, with the highest burden of severe disease being experienced by elderly people and by children under five years old.

          Why Was This Study Done?

          Annual immunization (vaccination) can reduce an individual’s risk of catching influenza, but before a country implements this preventative measure, policymakers need reliable estimates of the burden of influenza in their country. Although such estimates have been calculated for resource-rich countries with temperate climates, where influenza largely occurs in the winter, few estimates of influenza burden are available for resource-limited countries, which has hampered informed consideration of vaccination for influenza prevention in many settings. Recently, however, there has been a global expansion of systematic surveillance and testing for influenza virus among patients admitted to hospital for severe respiratory infection. Here, the researchers use this expanded surveillance data to provide an estimate of influenza-associated hospitalizations among children worldwide between 1982 and 2012. Specifically, they undertake a systematic review to identify published research articles on influenza-associated respiratory disease in hospitalized children, and, by aggregating the data from these articles with data collected by hospital-based influenza surveillance, they calculate a pooled estimate of the proportion of children hospitalized with respiratory disease who are positive for influenza.

          What Did the Researchers Do and Find?

          Using predefined search criteria, the researchers identified 108 published research articles that provided information on influenza-associated respiratory illness among hospitalized children. In addition, the Global Respiratory Hospitalizations–Influenza Proportion Positive (GRIPP) working group provided 37 hospital-based influenza surveillance datasets. By aggregating the data from these sources using a statistical approach called meta-analysis, the researchers calculated that, overall, influenza was associated with 9.5% of hospitalizations for severe respiratory infection among children under 18 years old worldwide, ranging from 4.8% among children under six months old to 16.4% among children aged 5–17 years. The researchers also calculated that, on average over the study period, influenza resulted in about 374,000 hospitalizations annually among children under one year old (including 228,000 hospitalizations among children less than six months old) and nearly one million hospitalizations annually among children under five years old. Finally, the researchers calculated that influenza-associated hospitalization rates among children under five years old over the study period were more than three times higher in resource-limited countries than in industrialized countries (150 and 48 hospitalizations, respectively, per 100,000 children per year).

          What Do These Findings Mean?

          Differences in hospitalization practices, in applications of case definitions, and in influenza testing protocols between settings may affect the accuracy of these findings. Specifically, the approach taken by the researchers may mean that their estimate of the total burden of severe respiratory disease due to influenza is an underestimate of the true situation. Even so, these findings suggest that influenza is an important contributor to hospitalizations for severe respiratory illness among children worldwide. Increasing influenza vaccination coverage among young children and pregnant women could, therefore, reduce the contribution that influenza makes to hospitalizations for respiratory infections among children. Importantly, the estimates of the burden of influenza provided by these findings can now be used by countries considering influenza vaccination programs for children and/or pregnant women to help them investigate the possible health and cost implications of such programs and should also stimulate further research into the development of effective influenza vaccines for young children.

          Additional Information

          This list of resources contains links that can be accessed when viewing the PDF on a device or via the online version of the article at http://dx.doi.org/10.1371/journal.pmed.1001977.

          Related collections

          Most cited references19

          • Record: found
          • Abstract: found
          • Article: not found

          Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis

          Summary Background The annual number of hospital admissions and in-hospital deaths due to severe acute lower respiratory infections (ALRI) in young children worldwide is unknown. We aimed to estimate the incidence of admissions and deaths for such infections in children younger than 5 years in 2010. Methods We estimated the incidence of admissions for severe and very severe ALRI in children younger than 5 years, stratified by age and region, with data from a systematic review of studies published between Jan 1, 1990, and March 31, 2012, and from 28 unpublished population-based studies. We applied these incidence estimates to population estimates for 2010, to calculate the global and regional burden in children admitted with severe ALRI in that year. We estimated in-hospital mortality due to severe and very severe ALRI by combining incidence estimates with case fatality ratios from hospital-based studies. Findings We identified 89 eligible studies and estimated that in 2010, 11·9 million (95% CI 10·3–13·9 million) episodes of severe and 3·0 million (2·1–4·2 million) episodes of very severe ALRI resulted in hospital admissions in young children worldwide. Incidence was higher in boys than in girls, the sex disparity being greatest in South Asian studies. On the basis of data from 37 hospital studies reporting case fatality ratios for severe ALRI, we estimated that roughly 265 000 (95% CI 160 000–450 000) in-hospital deaths took place in young children, with 99% of these deaths in developing countries. Therefore, the data suggest that although 62% of children with severe ALRI are treated in hospitals, 81% of deaths happen outside hospitals. Interpretation Severe ALRI is a substantial burden on health services worldwide and a major cause of hospital referral and admission in young children. Improved hospital access and reduced inequities, such as those related to sex and rural status, could substantially decrease mortality related to such infection. Community-based management of severe disease could be an important complementary strategy to reduce pneumonia mortality and health inequities. Funding WHO.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008.

            Age-specific comparisons of influenza and respiratory syncytial virus (RSV) hospitalization rates can inform prevention efforts, including vaccine development plans. Previous US studies have not estimated jointly the burden of these viruses using similar data sources and over many seasons. We estimated influenza and RSV hospitalizations in 5 age categories (<1, 1-4, 5-49, 50-64, and ≥65 years) with data for 13 states from 1993-1994 through 2007-2008. For each state and age group, we estimated the contribution of influenza and RSV to hospitalizations for respiratory and circulatory disease by using negative binomial regression models that incorporated weekly influenza and RSV surveillance data as covariates. Mean rates of influenza and RSV hospitalizations were 63.5 (95% confidence interval [CI], 37.5-237) and 55.3 (95% CI, 44.4-107) per 100000 person-years, respectively. The highest hospitalization rates for influenza were among persons aged ≥65 years (309/100000; 95% CI, 186-1100) and those aged <1 year (151/100000; 95% CI, 151-660). For RSV, children aged <1 year had the highest hospitalization rate (2350/100000; 95% CI, 2220-2520) followed by those aged 1-4 years (178/100000; 95% CI, 155-230). Age-standardized annual rates per 100000 person-years varied substantially for influenza (33-100) but less for RSV (42-77). Overall US hospitalization rates for influenza and RSV are similar; however, their age-specific burdens differ dramatically. Our estimates are consistent with those from previous studies focusing either on influenza or RSV. Our approach provides robust national comparisons of hospitalizations associated with these 2 viral respiratory pathogens by age group and over time.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Estimating household and community transmission parameters for influenza.

              A maximum likelihood procedure is given for estimating household and community transmission parameters from observed influenza infection data. The estimator for the household transmission probability is an improvement over the classical secondary attack rate calculations because it factors out community-acquired infections from true secondary infections. The mathematical model used does not require the specification of infection onset times and, therefore, can be used with serologic data which detect asymptomatic infections. Infection data were derived by serology and virus isolation from the Tecumseh Respiratory Illness Study and the Seattle Flu Study for the years 1975-1979. Included were seasons of influenza B and influenza A subtypes H1N1 and H3N2. The transmission characteristics of influenza B and influenza A(H3N2) and A(H1N1) outbreaks during this period are compared. Influenza A(H1N1), A(H3N2) and influenza B are found to be in descending order both in terms of ease of spread in the household and intensity of the epidemic in the community. Children are found to be the main introducers of influenza into households. the degree of estimation error from the misclassification of infected and susceptible individuals is illustrated with a stochastic simulation model. This model simulates the expected number of detected infections at different levels of sensitivity and specificity for the serologic tests used. Other sources of estimation error, such as deviation from the model assumption of uniform community exposure and the possible presence of superspreaders, are also discussed.
                Bookmark

                Author and article information

                Contributors
                Role: Academic Editor
                Journal
                PLoS Med
                PLoS Med
                plos
                plosmed
                PLoS Medicine
                Public Library of Science (San Francisco, CA USA )
                1549-1277
                1549-1676
                24 March 2016
                March 2016
                : 13
                : 3
                : e1001977
                Affiliations
                [1 ]Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
                [2 ]School of Health Sciences, University of Tampere, Tampere, Finland
                [3 ]Centre for Global Health Research, University of Edinburgh, Edinburgh, United Kingdom
                [4 ]Public Health Foundation of India, New Delhi, India
                [5 ]Afghanistan National Public Health Institute, Ministry of Public Health, Kabul, Afghanistan
                [6 ]National Directorate of Public Health, Ministry of Health, Luanda, Angola
                [7 ]National Centre for Immunisation Research and Surveillance, The Children’s Hospital at Westmead, Westmead, New South Wales, Australia
                [8 ]Institute of Epidemiology, Disease Control and Research, Dhaka, Bangladesh
                [9 ]Division of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Centre for Disease Control and Prevention, Beijing, China
                [10 ]Caja Costarricense de Seguro Social, San José, Costa Rica
                [11 ]Pasteur Institut of Côte d’Ivoire, Abidjan, Côte d’Ivoire
                [12 ]Ministerio de Salud de El Salvador, San Salvador, El Salvador
                [13 ]Ethiopian Public Health Institute, Addis Ababa, Ethiopia
                [14 ]Medical Research Council Unit, Fajara, The Gambia
                [15 ]Department of Paediatrics, University of Auckland, Auckland, New Zealand
                [16 ]Centre for International Health, University of Otago, Dunedin, New Zealand
                [17 ]Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana
                [18 ]Ministerio de Salud Publica y Asistencia Social, Guatemala City, Guatemala
                [19 ]National Institute of Virology, Pune, India
                [20 ]National Institute of Health Research and Development, Jakarta, Indonesia
                [21 ]Centers for Disease Control and Prevention, Nairobi, Kenya
                [22 ]Ministry of Health, Bishkek, Kyrgyzstan
                [23 ]National Influenza Centre, Virology Unit, Institut Pasteur of Madagascar, Antananarivo, Madagascar
                [24 ]Universidad Autónoma de San Luis Potosí, San Luis Potosí, Mexico
                [25 ]National Centre for Public Health, Chisinau, Republic of Moldova
                [26 ]National Influenza Center, Ulaanbaatar, Mongolia
                [27 ]Institut National d’Hygiène, Ministère de la Santé, Rabat, Morocco
                [28 ]Federal Ministry of Health, Abuja, Nigeria
                [29 ]Ministerio de Salud Publica y Bienestar Social, Asunción, Paraguay
                [30 ]Research Institute for Tropical Medicine, Manila, Philippines
                [31 ]Ministry of Health, Kigali, Rwanda
                [32 ]National Institute for Communicable Diseases, Johannesburg, South Africa
                [33 ]Zoonoses Research Unit, Department Medical Virology, University of Pretoria, Pretoria, South Africa
                [34 ]Division of Global Health Protection, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
                [35 ]Ministry of Health, Dar es Salaam, Tanzania
                [36 ]National Institute of Health, Ministry of Public Health, Nonthaburi, Thailand
                [37 ]National Institute of Hygiene and Epidemiology, Hanoi, Viet Nam
                [38 ]Virology Laboratory, University Teaching Hospital, Lusaka, Zambia
                Makerere University Medical School, UGANDA
                Author notes

                We have read the journal's policy and have the following competing interests: DEN has participated on an influenza advisory board for Novartis. RB works with all major manufacturers of influenza vaccines in an advisory capacity, as a researcher on vaccines and as presenter of academic info at conferences, receiving support to travel and attend such conferences. The authors have declared that no other competing interests exist.

                Conceived and designed the experiments: KEL HN MAW. Performed the experiments: KEL MW EAB MAW. Analyzed the data: KEL HN EAB MAW. Contributed reagents/materials/analysis tools: KEL HN MW. Wrote the first draft of the manuscript: KEL. Contributed to the writing of the manuscript: MAW. Enrolled patients: MHR FV RB MR PK HY GG DC JA DJ SH WA RM MCha ODS GOE ZN AC JMH DEN RC PN AB AA MvH RO TN MV VM MChi THN AT GRIPP-WG. Agree with the manuscript’s results and conclusions: KEL HN MHR FV RB MR PK HY GG DC JA DJ SRCH WA RM MCha ODS GOE ZN AC JMH DEN RC PN AB AA MvH RO TN MV VM MChi THN AT MW EAB JB HC MAW GRIPP-WG. All authors have read, and confirm that they meet, ICMJE criteria for authorship.

                ¶ Membership of the GRIPP Working Group is provided in the Acknowledgments.

                Article
                PMEDICINE-D-15-00668
                10.1371/journal.pmed.1001977
                4807087
                27011229
                32987219-ba6e-4e34-94f7-1fb83b8d029e

                This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

                History
                : 3 March 2015
                : 5 February 2016
                Page count
                Figures: 2, Tables: 3, Pages: 19
                Funding
                Funding for this study was provided entirely by the U.S. Centers for Disease Control and Prevention (CDC). The study was designed by the authors, and the results and conclusions do not necessarily reflect the official position of the CDC.
                Categories
                Research Article
                Medicine and Health Sciences
                Infectious Diseases
                Viral Diseases
                Influenza
                Biology and life sciences
                Organisms
                Viruses
                RNA viruses
                Orthomyxoviruses
                Influenza Viruses
                Biology and Life Sciences
                Microbiology
                Medical Microbiology
                Microbial Pathogens
                Viral Pathogens
                Orthomyxoviruses
                Influenza Viruses
                Medicine and Health Sciences
                Pathology and Laboratory Medicine
                Pathogens
                Microbial Pathogens
                Viral Pathogens
                Orthomyxoviruses
                Influenza Viruses
                Biology and Life Sciences
                Organisms
                Viruses
                Viral Pathogens
                Orthomyxoviruses
                Influenza Viruses
                Medicine and Health Sciences
                Pulmonology
                Respiratory Infections
                Medicine and Health Sciences
                Epidemiology
                Disease Surveillance
                Infectious Disease Surveillance
                Medicine and Health Sciences
                Infectious Diseases
                Infectious Disease Control
                Infectious Disease Surveillance
                People and Places
                Population Groupings
                Age Groups
                Biology and Life Sciences
                Immunology
                Vaccination and Immunization
                Medicine and Health Sciences
                Immunology
                Vaccination and Immunization
                Medicine and Health Sciences
                Public and Occupational Health
                Preventive Medicine
                Vaccination and Immunization
                Medicine and Health Sciences
                Pediatrics
                Medicine and Health Sciences
                Pediatrics
                Pediatric Infections
                Custom metadata
                All relevant data are provided within the paper and its Supporting Information files.

                Medicine
                Medicine

                Comments

                Comment on this article